Conference Reports for NATAP

Back

5th European HIV Drug Resistance Workshop (EHDRW 2007), Cascais, Portugal, March 28-30, 2007     Estimated potency of six different boosted protease inhibitors regimens in antiretroviral-experienced HIV patients - Impact of baseline protease resistance mutations (04/09/07)   First ART Response After Genotyping: T215 Revertants Signal Danger (04/02/07)   Good HBV Response to Tenofovir After Lamivudine Failure (04/02/07)   HBV Mutations With Monotherapy Versus Combination Therapy (04/02/07)   Upper and Lower Clinical Cutoffs Proposed for Darunavir from Monogram (04/02/07)   Darunavir Phenotype Predicts Response Better Than Genotype (04/02/07)   Total Mutation Number--and Specific Mutations--Predict Death (04/02/07)   Response to Darunavir, Tipranavir, or Lopinavir After Atazanavir Failure (03/30/07)   Few Integrase Inhibitor (INI) Mutations in INI-Naive People (03/30/07)   Accuracy of Monogram's Trofile Assay in Determining Tropism and New Tropism Assays in Development (03/30/07)   Several Genotyping Systems Offer Hope as Tropism Predictors (03/30/07)   Prediction of HIV-1 coreceptor usage based on structural descriptors of the gp120 V3 loop (03/30/07)   Evolving Resistance Pattern Before Antiretroviral Therapy Starts (03/30/07)   Correlation of Resistance Algorithms for Tipranavir Susceptibility with Response to Tipranavir Containing Regimens in the RESIST Trials (03/30/07)   Mutations associated with cross-resistance to tipranavir in patients previously treated with two or more protease inhibitors (03/30/07)   Darunavir Exhibits High Levels of In Vitro Antiviral Activity against Clinical Samples with Different Levels of Susceptibility to Atazanavir/Ritonavir (03/30/07)   Waning Incidence of Multidrug-Resistant HIV in Europe? - written by Mark Mascolini (03/29/07)   Rescue Regimen Success Rises 18% Yearly in Italian Cohort - written by Mark Mascolini (03/29/07)   Hard to Pinpoint Factors Favoring Infection With Resistant HIV - written by Mark Mascolini (03/29/07)   Prevalence of Darunavir Resistance-Associated Mutations in Samples Received for Routine Clinical Resistance Testing (03/29/07)   Low Rates of Darunavir Mutations After Failure of Other PIs - written by Mark Mascolini (03/29/07)